Navigation Links
HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market
Date:9/15/2011

LOS ALTOS HILLS, Calif., Sept. 15, 2011 /PRNewswire/ -- HealthTech Capital, a Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market, announced today that it has closed two new investment deals. PharmaSecure received more than $200,000 from HealthTech Capital members in a Series B syndicated venture round that included Gray Ghost Ventures and others, while Niveus Medical received $600,000 in a Series A syndicated financing of approximately $2 million, which also included Band of Angels, Life Science Angels, Sand Hill Angels, and other angel and venture capital groups. Today's announcement underscores the growing use of investment syndications to support early-stage companies that reduce healthcare costs through technology innovation.

"With healthcare costs continuing to spiral out of control, companies that decrease costs by leveraging new technologies are providing very attractive investment opportunities," said Anne DeGheest, a HealthTech pioneer with her firm Medstars and a cofounder and managing director of HealthTech Capital. "PharmaSecure and Niveus Medical are well positioned to be the next wave of successful HealthTech companies, and we are delighted to work closely with such great entrepreneurs."

"With the early-stage funding gap, HealthTech Capital is stepping up to syndicate, or pool, investments with other angel groups to fund early-stage companies," said Don Ross, HealthTech Capital cofounder and managing director and Sand Hill Angels board director. "In addition, HealthTech Capital accelerates its portfolio companies through their early stages by providing hands-on mentoring as well as investment dollars. With both PharmaSecure and Niveus Medical, HealthTech Capital members became involved long before the investments and will continue to provide added-value mentoring going forward."

PharmaSecure uses cell phone technology to combat the global problem of counterfeit drugs. On each bubble pack of pills, the company prints a unique code and phone number so consumers can verify the drug's authenticity with an SMS text message. PharmaSecure has significant traction in India, driven by recent legislation changes.

"HealthTech Capital's leadership and members are experienced investors with in-depth understanding of healthcare and technology and the intersection of the two industries," said Nathan Sigworth, CEO of PharmaSecure. "We are pleased that our product is achieving such global acceptance and appreciate having HealthTech Capital as an investor to help us with product expansion."

Niveus Medical is developing a technology to preserve muscle strength during long periods of sedation and bed rest. By reducing muscle debilitation, the company intends to shorten hospital stays, especially time in the intensive care unit, and provide significant cost savings.

"We are delighted to have HealthTech's participation in this funding round, which will help us validate the benefits our technology brings to patients, as well as the cost savings it can deliver to the healthcare system," said Brian J. Fahey, CEO of Niveus Medical.

About PharmaSecure

PharmaSecure is a global innovator in drug authentication technologies and software, creating effective solutions to ensure consumers receive authentic medications from trusted pharmaceutical manufacturers in emerging markets. Founded in 2007, PharmaSecure is a fast-growing company offering services in the United States, Europe, India, Africa, and Southeast Asia. The company is based in Lebanon, NH.

About Niveus Medical

Niveus Medical has developed a series of novel technologies to reduce or prevent debilitation and thereby accelerate patient recovery, shorten hospital stays, and reduce both hospital and payer costs. The company's solution is the first to prevent muscle deterioration in patients who are sedated and cannot participate in physical therapy. Early testing shows Niveus technologies to be easily used by nursing staff and well-accepted by patients. Niveus Medical is based in Palo Alto, Calif.

About HealthTech Capital

HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where digital innovation improves healthcare delivery and empowers patients. HealthTech Capital is led by proven investors and visionaries in health care and technology. Its members are industry leaders – successful entrepreneurs, executives, physicians and venture capitalists – with expertise in healthcare and new information and mobile technologies. In addition to funding and mentoring new companies, the group facilitates syndication with other angel investors, venture capitalists and corporations for funding and other opportunities. For more information on HealthTech Capital, please visit www.HealthTechCapital.com.


'/>"/>
SOURCE HealthTech Capital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences
2. Main Street Capital Announces New Portfolio Investment
3. MGT Capital Investments, Inc.s Plan of Compliance Accepted by NYSE AMEX, LLC
4. CVS Caremark Corporation Announces Receipt of Requisite Consents, Termination of Replacement Capital Covenant and Expiration of Consent Solicitation Relating to its 6.125% Senior Notes due August 15, 2016 (CUSIP NO. 126650BE9)
5. MGT Capital Investments, Inc. Provides Update on Recent Developments
6. KPS Capital Partners to Sell Attends Healthcare, Inc. to Domtar Corporation for $315 Million
7. Vycor Medical, Inc. Completes Final Close on Equity Capital Raise
8. HASCO Medical Chairman Provides $2 Million in Capital and a Personal Guarantee on Additional $2 Million Promissory Note
9. Foundation Venture Capital Group Investment Shows Promise in Diagnosis of Alzheimers Disease Using a Drop of Blood
10. Report on HIV Prevention Research Funding Says New Investment Critical to Capitalize on HIV Prevention Research Breakthroughs
11. CSA Medical Completes $12.6 Million Series A Financing With Additional Venture Investment From Blue Heron Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016  Varian Medical Systems (NYSE: ... its previously announced plans to separate its Imaging Components ... a tax-free distribution to Varian stockholders of common stock ... that will hold the Imaging Components business.  As part ... executed by the end of January 2017, Varian will ...
(Date:12/7/2016)... , Dec. 7, 2016  Organovo Holdings, Inc. ... biology company focused on delivering scientific and medical ... that Chairman and Chief Executive Officer Keith ... on Wednesday, December 14, 2016 at 1:00 p.m. ... are not yet familiar with the Company, an ...
(Date:12/7/2016)... (NYSE: LCI ) today announced that the company will ... Conference on December 14, 2016 at 9:20 a.m. (ET) at the ... In addition, the company will host one-on-one meetings with ... Boston Healthcare Conference taking place on December 13, 2016 at the ... , , ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... One of two ... of the securement tape is painful for her. "This is why the co-inventor and ... heads," she said. , They then created a prototype of the patent-pending AV-AIR, a ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, ... ... mystery. A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... in dogs. The study was published in the prestigious Journal of Veterinary Science ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Facial plastic surgeon, ... holiday season by donating a portion of proceeds to two local organizations: North Chicago ... Animal Control & Friends is a team of authorized and trained volunteers who ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... a 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. ... Awards recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is ... Awards under the Best New Product Launch category. Gensuite’s entry on their EZ ... , BOC Global Events & Training Group is a professional event and training ...
Breaking Medicine News(10 mins):